| answer text |
<p>The UK is at the forefront of efforts to develop coronavirus vaccines. As agreed
by the G20, we support a global approach to the rapid development and scaled up manufacture
of vaccines with equitable access to all who need them, including in the poorest countries.
We are working with international partners, industry and researchers to support an
approach to accelerate research and development, scale up global manufacturing capacity
and ensure funding to deliver this aim.</p><p>The UK is a strong supporter of the
Coalition for Epidemic Preparedness Innovations (CEPI), which is supporting the development
of vaccines that will be available throughout the world. We have pledged £250 million
of UK aid to CEPI, the biggest donation of any country to date. CEPI is supporting
the development of 10 COVID-19 vaccine candidates, such as the University of Oxford’s
vaccine research.</p><p>UK aid has also supported Gavi, the Vaccine Alliance for 20
years. We are its biggest donor, helping to immunise over 760 million children and
saving over 13 million lives worldwide. Gavi will play a key role in making a new
COVID-19 vaccine available and affordable.</p><p>UK support, through CEPI, GAVI and
others, will help facilitate the end-to-end development and distribution of a successful
vaccine.</p>
|
|
